"Medtronic begins Embrace Gynecology study of Hugo RAS system" was originally created and published by Medical Device Network, a GlobalData owned brand.
The use of GLP-1RAs may improve RA disease activity and cardiovascular risk profiles among patients with overweight or obesity.
The company will provide CRO and testing services for the ADAPT program to guide the project's clinical trials.